Clinical Trials on Japanese in United Kingdom
Total 16 results
-
UCB Biopharma S.P.R.L.CompletedHealthy Japanese VolunteersUnited Kingdom
-
AstraZenecaCompletedPharmacokinetics | Bioequivalence | Healthy Japanese SubjectsUnited Kingdom
-
UCB Biopharma S.P.R.L.CompletedHealthy Japanese and Caucasian SubjectsUnited Kingdom
-
Valneva Austria GmbHWithdrawnJapanese EncephalitisUnited Kingdom
-
University of LiverpoolCompleted
-
Agios Pharmaceuticals, Inc.CompletedHealthy | Japanese | Non-AsianUnited States
-
AstraZenecaCompletedHealthy Japanese VolunteersUnited States
-
PfizerCompletedHealthy Male and Female Japanese VolunteersUnited States
-
Richmond Pharmacology LimitedCompletedEffects of Different Meals on the QT/QTc Interval | Insulin and Oral Hypoglycemic [Antidiabetic] Drugs Causing Adverse Effects in Therapeutic Use | C-Peptide Effects on the QT/QTc Interval | Moxifloxacin ECG Profile in Fed and Fasted State | Japanese vs. Caucasian TQT ComparisonUnited Kingdom
-
MedImmune LLCCompletedPart I (SAD) - Healthy Participants | Part II (MAD) - Chronic Obstructive Pulmonary Disease | Part III (J-SD) - Healthy Japanese ParticipantsUnited Kingdom
-
Valneva Austria GmbHCompleted
-
SanofiPRA Health SciencesCompletedJapanese EncephalitisUnited States
-
Valneva Austria GmbHCompletedJapanese EncephalitisAustralia, United States, Germany
-
Valneva Austria GmbHCompletedEncephalitisUnited States, Australia, Denmark, Germany, Sweden
-
SanofiCompletedJapanese EncephalitisAustralia, United States
-
SanofiCompletedJapanese Encephalitis | EncephalitisUnited States, Australia